marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Axsome Therapeutics Cash Flow 2011-2024 | AXSM
Annual Cash Flow Axsome Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-145 M | -117 M | -108 M | -78.5 M | -46.4 M | -30.1 M | -26.5 M | -21.3 M | -7.44 M | -4.6 M | - | - | - |
Depreciation & Amortization |
459 K | 263 K | 76 K | 23.9 K | 37.3 K | 48.9 K | 42.6 K | 20.5 K | 3.54 K | - | - | - | - |
Accounts Payables |
40.7 M | 38.6 M | 13.1 M | 13.5 M | 10.9 M | 3.69 M | 3.44 M | 4.08 M | - | - | - | - | - |
Accounts Receivables |
94.8 M | 37.7 M | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
15.1 M | 4.32 M | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Axsome Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -53.5 M | - | - | - | -5.82 M | - | -88.9 M | -66.2 M | -32.7 M | - | -79.4 M | -52.6 M | -27.2 M | - | -57.9 M | -42.2 M | -23.3 M | - | -28.8 M | -18.2 M | -9.5 M | - | -20.3 M | -14.3 M | -6.68 M | - | -20.2 M | -13.7 M | -6.64 M | - | -14.1 M | -9.26 M | -3.95 M | - | -5.19 M | -3.27 M | -1.16 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
1.61 M | 1.59 M | 132 K | - | 1.61 M | 1.59 M | 90 K | - | 1.61 M | 926 K | 36.6 K | - | 45.3 K | 18.1 K | 8.33 K | - | 16.5 K | 11 K | 5.44 K | - | 31.9 K | 22.5 K | 11.4 K | - | 36.7 K | 23.7 K | 11.9 K | - | 31.3 K | 20.5 K | 10.1 K | - | 10.7 K | 5.12 K | 2.11 K | - | 2.29 K | 1.17 K | 304 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
64.3 M | 61.3 M | 53.8 M | 40.7 M | 29.1 M | 43 M | - | 38.6 M | 12.8 M | 19.4 M | 12.6 M | 13.1 M | 13.4 M | 11.6 M | 14.6 M | 13.5 M | 13.5 M | 13.5 M | 13.5 M | 10.9 M | 10.9 M | 10.9 M | 10.9 M | 3.69 M | 3.69 M | 3.69 M | 3.69 M | 3.44 M | 3.44 M | 3.44 M | 3.44 M | 4.08 M | 4.08 M | 4.08 M | 4.08 M | 1.89 M | 1.89 M | 1.89 M | 1.89 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
124 M | 120 M | 101 M | 94.8 M | 78.4 M | 67.4 M | - | 37.7 M | 20.3 M | 16.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
14.3 M | 15.2 M | 15.6 M | 15.1 M | 9.98 M | 9.25 M | - | 4.32 M | 2.1 M | 10.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency